Open AccessEfficacy and safety of non-vitamin K antagonist oral anticoagulants post-kidney transplantation
Author(s) -
Muhammad Bukhari,
Abdulrahman Altheaby,
Mohammed Tawhari,
Ali Al-Shaggag,
Ryan Pyrke,
Azim S. Gangji,
Darin Treleaven,
Christine M. Ribic
Publication year - 2019
Publication title -
world journal of transplantation
Language(s) - English
Resource type - Journals
ISSN - 2220-3230
DOI - 10.5500/wjt.v9.i6.134
Subject(s) - medicine , apixaban , rivaroxaban , dabigatran , transplantation , kidney transplantation , vitamin k antagonist , kidney disease , edoxaban , warfarin , atrial fibrillation
Novel oral anticoagulants (NOACs) were developed as alternatives to vitamin K antagonists, primarily warfarin, as they do not require routine monitoring and have limited drug-drug and drug-food interactions. However, the efficacy and safety of these agents in kidney transplantation are not well studied.